Found 9 matching trials
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes PHASE1 RATIONALE: Drugs used in chemotherapy, such as clofarabine and cytarabine, ...
Show More Location
University of Nebraska Medical Center
Learn More & Join Trial
Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes PHASE2 This is an interventional, multicenter, open label, phase II study designed...
Show More Location
SC Ematologia-AO SS.Antonio e Biagio e Cesare Arrigo
Learn More & Join Trial
Clofarabine and Low-dose Cytarabine Followed by Consolidation Therapy in AML Patients Age Greater Than or Equal to 60 Years PHASE2 Primary outcome measure:
Evaluate the efficacy in terms of complete respon...
Show More Location
Hospital Juan Canalejo.
Learn More & Join Trial
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma PHASE2 The overarching objective of this study is to use novel precision medicine ...
Show More Status
Active Not Recruiting
Location
Lucile Packard Children's Hospital Stanford University
Learn More & Join Trial
Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS PHASE1 This phase I/II trial studied the side effects and best dose of clofarabine...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia PHASE3 The primary objective of this study is to demonstrate the efficacy of Iomab...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) PHASE2 The goal of this clinical research study is to learn if clofarabine given i...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS). PHASE2 The goal of this clinical research study is to study how effective treatmen...
Show More Location
M.D. Anderson Cancer Center
Learn More & Join Trial
Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) PHASE2 The goal of this clinical research study is to learn if clofarabine when gi...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial